Route 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial Officer
September 18 2023 - 9:00AM
Route 92 Medical, Inc., a privately held medical technology company
dedicated to improving outcomes for patients undergoing
neurovascular intervention, today announced the appointment of
Jonathan Kennedy to the role of Chief Financial Officer. In this
role, Jonathan will be responsible for overseeing all financial
management for the company, reporting directly to Chief Executive
Officer Tony Chou.
“Route 92 Medical’s technology offers uniquely disruptive
solutions in the rapidly growing stroke treatment market. The
company is well-positioned for long-term growth, continued product
innovation, and meaningful improvements in patient outcomes, which
makes this an exciting time to join,” said Jonathan Kennedy, Chief
Financial Officer for Route 92 Medical. “Expanding the Company’s
critical business infrastructure to support this type of growth
will accelerate Route 92 Medical’s success.”
Jonathan joins Route 92 Medical after an eight-year stint as
Chief Executive Officer and Chief Financial Officer at Natus
Medical, a neurology, newborn care, hearing, and balance company.
At Natus (Nasdaq:NTUS), he helped build a multi-site, multinational
business via acquisition, innovation, and best-in-class customer
service. Prior to that, Jonathan served as Senior Vice President
and Chief Financial Officer for Intersil Corporation, now part of
Renesas, which designs and manufactures high-performance analog
semiconductors. During his tenure, he held leadership roles
overseeing finance, IT, investor relations/SEC reporting, sales
analytics, and mergers and acquisitions. Jonathan holds a BS in
Business Administration and Accounting and an MS in Accounting from
the University of Central Florida, and earned his CPA in
Florida.
“Jonathan has managed very large product portfolios and complex
business situations in hypercompetitive markets. He is a leader
with a demonstrated history of delivering outstanding financial
growth across a variety of companies and industries,” said Tony
Chou, Chief Executive Officer and Founder at Route 92 Medical.
“Route 92 Medical is fortunate to have someone with his extensive
experience joining our team as we work together to transform
neurovascular intervention.”
About Route 92 Medical, Inc.Route 92 Medical is
on a mission to improve outcomes for patients undergoing
neurovascular intervention through cutting-edge engineering and
innovative product design. Founded by physicians, the company
collaborates with leading neurovascular clinicians to solve the
biggest challenges in neurointervention and deliver meaningful,
differentiated solutions that promote clinical success. For more
information, visit www.route92medical.com or follow the company on
LinkedIn.
Media Contact
Gwen Gordongwen@gwengordonpr.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/16770d06-5a50-4d0a-8d98-db882e9cb9e2
Natus Medical (NASDAQ:NTUS)
Historical Stock Chart
From Oct 2024 to Nov 2024
Natus Medical (NASDAQ:NTUS)
Historical Stock Chart
From Nov 2023 to Nov 2024